Hypera Stock

Hypera Operating Cash Flow

The Operating Cash Flow of Hypera (HYPE3.SA) as of Aug 7, 2026 is 2.57 B BRL. In the previous year, Operating Cash Flow was 2.54 B BRL — a change of 1.37% (higher).

Operating Cash Flow

2.57 BBRL

YoY

1.37%

Last updated:

Operating Cash Flow of Hypera is 2026 2.57 B BRL. Operating Cash Flow of Hypera was 2025 2.54 B BRL. It decreases by 1.37% higher compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

Operating Cash Flow of Hypera is 2.57 B BRL in 2026.

Operating Cash Flow of Hypera changed from 2.54 B BRL to 2.57 B BRL, representing a 1.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Hypera since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Hypera historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Hypera

All Key Metrics — Hypera